The St. Jude scandal refers to a series of investigative findings, led by ProPublica beginning in 2021, that exposed a gap between the Memphis hospital’s famous “no bills” promise and the costs families actually bear, documented billions of dollars accumulating in reserves while patient families went into debt, and detailed aggressive litigation by the hospital’s fundraising arm against the families of deceased donors. St. Jude Children’s Research Hospital is the country’s highest-earning health charity, and the reporting prompted a watchdog downgrade, policy changes, and a continuing debate over how its money is spent.
What the “No Bills” Promise Actually Covers
St. Jude tells donors and the public that families “never receive a bill” for treatment, travel, housing, or food. ProPublica’s November 2021 investigation found the promise is narrower than the marketing suggests.
The hospital does not bill families for medical care, but its assistance is capped. At the time of the investigation, St. Jude covered travel and housing for only one parent. Food stipends were capped at $50 per day per family regardless of size. And St. Jude does not cover lost wages, which is often the largest financial hit when a parent quits a job or takes unpaid leave to be with a sick child.
About 90% of St. Jude patients have private insurance or Medicaid, which pays a substantial share of treatment costs; St. Jude covers the remaining copays and deductibles. None of that addresses the income a family loses during months or years of treatment.
ProPublica documented families who drained savings, took on debt, and turned to GoFundMe or outside charities to keep up with rent, car payments, and utilities. A school bus driver slept in his truck in the hospital parking lot because housing was provided for only one parent, and watched his credit score collapse. A family of five lived in a single room for 50 days while the $50 daily food credit failed to feed them, running up $20,000 in debt. One mother exhausted $10,000 in savings she had set aside for a home down payment, then stopped bringing her son to St. Jude altogether after finding her local hospital in Tulsa could deliver the same treatment regimen. The head of the Andrew McDonough B+ Foundation, a charity St. Jude social workers themselves referred families to, told ProPublica the hospital’s marketing creates a public perception of total financial relief that does not match reality.
Billions in Reserves
The financial dimension of the scandal centers on how much money St. Jude has accumulated while families struggle. As of June 2020, the hospital held $5.2 billion in reserves, enough to fund operations at then-current levels for four and a half years with no further donations. The reserve had grown 58% over the preceding five fiscal years, with an average of $400 million added annually from 2016 through 2020.
By June 2021, the reserve had reached $7.6 billion after the hospital set aside $886 million in unspent revenue in a single year. ProPublica reported that during fiscal years 2015 through 2019, only about half of the $7.3 billion in contributions went to hospital research and patient care. Roughly 30% covered fundraising operations and 20% was added to reserves. Direct spending on families for food, travel, and housing came to about $40 million per year, or roughly 2% of funds raised.
The most recent IRS Form 990 filing, for the fiscal year ending June 2024, shows St. Jude Children’s Research Hospital Inc. with total assets of about $11.65 billion and net assets of $11.32 billion. ALSAC, the separate fundraising entity, reported total assets of roughly $9.99 billion and net assets of $9.84 billion for the same period. Total hospital revenue for fiscal year 2024 was about $2 billion against total expenses of $1.77 billion, so the institution continued to take in more than it spent.
Accounting and health policy experts quoted by ProPublica called the reserve accumulation “staggering” and accused the hospital of “hoarding” funds. Critics also noted that St. Jude’s dominant fundraising made it harder for smaller pediatric cancer charities, many of which run their own research and clinical trials, to raise money.
Suing Donors’ Families Over Estates
A separate ProPublica investigation published in March 2022 found that ALSAC has aggressively litigated against the families of deceased donors to secure shares of their estates. Bequests are a major revenue stream: over one five-year period they totaled $1.5 billion, or 20% of the $7.5 billion raised. An ALSAC lawyer testified in 2017 that the charity was then involved in more than 100 legal fights over disputed estates. ALSAC has said it litigates less than 1% of the thousands of estate donations it receives annually.
The reporting detailed several disputes. Eugene Lanier’s will directed $100,000 to St. Jude from the sale of his home; his son Vance argued the home had been placed in a trust for the children years earlier and was not part of the estate. St. Jude pursued the claim through multiple courts, and Vance Lanier spent $50,000 in legal fees before St. Jude lost at the state Supreme Court level.
Nona and J.D. Harris had planned to leave nearly $6 million to St. Jude. After Nona died, J.D. revised his plan to split the estate between the hospital and family members. St. Jude challenged the revised trust. A Tulsa district court upheld it in 2019, an appeals court affirmed, and the family received its share in 2020.
After the death of Theodore Scheide Jr., whose will disinherited his biological son and named St. Jude as a beneficiary, the original will went missing. St. Jude petitioned to probate a copy. The Nevada Supreme Court ruled in the charity’s favor in 2020, relying in part on testimony from an attorney who had simultaneously served as counsel for both the hospital and the deceased donor.
ALSAC maintained that it only initiates litigation when “due diligence reveals substantial evidence” of a “curtailment of the donor’s actual intent” and that the bequest program “operates with the highest ethical standards.” One person who successfully contested a St. Jude claim asked ProPublica: “Think of all the fees for lawyers that didn’t go to St. Jude, not one child, not one cancer patient. Where is the sanity in all this?”
How Charity Watchdogs Responded
In June 2022, CharityWatch downgraded St. Jude from a B to a C, applying its standard that a nonprofit’s grade is reduced when available reserves exceed three years of its annual cash budget. St. Jude’s reserves at the time equaled roughly 3.7 years of operating expenses. CharityWatch issued a minor correction days later clarifying that St. Jude did meet its benchmarks for governance and transparency.
Other evaluators have been more favorable. As of 2024, Charity Navigator gave ALSAC/St. Jude a four-star rating with an overall score of 99%. The BBB Wise Giving Alliance, in a report issued in December 2024 and valid through December 2026, accredited the organization as meeting all 20 of its standards for charity accountability, while noting that unrestricted net assets were “slightly above the limit” of its benchmark.
Executive pay has also drawn attention. St. Jude’s fiscal year 2024 Form 990 shows President and CEO James R. Downing received about $2.37 million in compensation, with several other hospital executives earning more than $1 million. ALSAC CEO Richard C. Shadyac Jr. received about $1.46 million for the fiscal year ending June 2024. St. Jude says executive compensation is set by a committee of independent board members advised by an outside expert.
What St. Jude Changed After the Reporting
Following ProPublica’s first investigation, St. Jude expanded family benefits effective November 15, 2021. The changes:
- Travel coverage for two parents instead of one.
- Regular travel for siblings and other family members.
- Hotel reimbursement for families living more than 400 miles from the hospital.
- A restructured food allowance of $25 per day per individual family member, replacing the flat $50 per family cap.
- A weekly stipend for families in long-term housing raised from $125 to $150.
St. Jude did not change its policy on lost wages, which remains uncovered.
What St. Jude Says in Its Defense
The hospital rejects the characterization of its finances. St. Jude says it has “never promised anyone — neither patients nor the public in general — that it can solve all financial problems,” and describes its reserves as a “prudent cushion” needed because the institution is “highly donor-dependent and subject to the economic driven vagaries of charitable giving.” Legal counsel for the hospital wrote to ProPublica that the outlet “should be celebrating St. Jude and ALSAC for their commitment to finding cures, saving children’s lives, and optimizing patient outcomes.”
The hospital also points to spending plans and research results. St. Jude expects annual costs to rise to $2.2 billion by fiscal year 2026 and has published a $12.9 billion, six-year strategic plan running through fiscal 2027, the largest investment in its history, covering construction, 2,300 new jobs, and $100 million annually for global initiatives. On the research side, overall childhood cancer survival rates in the United States have risen from 20% to more than 80% since St. Jude’s founding, and survival for acute lymphoblastic leukemia, the most common childhood cancer, has risen from 4% to 94%. The World Health Organization designated St. Jude in 2018 as its only Collaborating Centre for childhood cancer, a designation renewed in June 2026.
Those results, and the hospital’s argument that long-horizon research requires large reserves, sit alongside the findings that drove the scandal: families going into debt within the “no bills” system, billions accumulating faster than they are spent, and bequest fights with the relatives of the donors who built the endowment.